Cargando…

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children

In this multicenter study, we identified an increased risk of 30-day mortality among hospitalized children with carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical cultures compared with those with carbapenem-susceptible Enterobacteriaceae. We additionally report significant variati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiotos, Kathleen, Tamma, Pranita D, Flett, Kelly B, Karandikar, Manjiree V, Nemati, Koorosh, Bilker, Warren B, Zaoutis, Theoklis, Han, Jennifer H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186173/ https://www.ncbi.nlm.nih.gov/pubmed/30338267 http://dx.doi.org/10.1093/ofid/ofy222

Ejemplares similares

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms
por: Simner, Patricia J, et al.
Publicado: (2018)

417. Factors associated with 30-day Mortality in Carbapenems-resistant Enterobacteriaceae Infections
por: Osaithai, Naphol, et al.
Publicado: (2022)

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis
por: Fabre, Valeria, et al.
Publicado: (2018)

Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?
por: Pana, Zoi Dorothea, et al.
Publicado: (2018)

1588. Clinical Prediction Tool for Extended-Spectrum Β Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients
por: Wang, Rebecca, et al.
Publicado: (2018)

Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
por: Chiotos, Kathleen, et al.
Publicado: (2017)

371 Outcomes of Enterobacter bloodstream infection in hospitalized children
por: Larru, Beatriz, et al.
Publicado: (2014)

Comparison of 30- and 90-Day Mortality Rates in Patients with Cultures Positive for Carbapenem-resistant Enterobacteriaceae and Acinetobacter in Atlanta, 2011–2015
por: Sexton, Mary Elizabeth, et al.
Publicado: (2017)

Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bacteremia
por: Wang, Ruibin, et al.
Publicado: (2016)

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017)

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Luterbach, Courtney L, et al.
Publicado: (2018)

The Predominance of Klebsiella aerogenes among Carbapenem-Resistant Enterobacteriaceae Infections in Japan
por: Kamio, Kosuke, et al.
Publicado: (2022)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Evaluation of phenotypic tests to detect carbapenem-resistant Enterobacteriaceae in colonized patients hospitalized in intensive care units
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2015)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Epidemiologic and Microbiologic Characteristics of Hospitalized Patients Co-colonized With Multiple Species of Carbapenem-Resistant Enterobacteriaceae in the United States
por: Adediran, Timileyin, et al.
Publicado: (2020)

Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections
por: Shields, Ryan K, et al.
Publicado: (2023)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

Risk factor for mortality associated with carbapenem-resistant Enterobacteriacea infections
por: Carrilho, Cláudia MDM, et al.
Publicado: (2013)

Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection
por: So-ngern, Apichart, et al.
Publicado: (2023)

Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii
por: Lv, Dongmei, et al.
Publicado: (2022)

1443. Nontuberculous Mycobacterial Cervicofacial Lymphadenitis Therapy: Experience from a Tertiary Care Pediatric Center
por: Vo, Anh N, et al.
Publicado: (2022)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae
por: Armin, Shahnaz, et al.
Publicado: (2023)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae
por: Li, Xiaopeng, et al.
Publicado: (2017)

Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
por: McConville, Thomas Howe, et al.
Publicado: (2017)

Differential DNA accessibility to polymerase enables 30-minute phenotypic β-lactam antibiotic susceptibility testing of carbapenem-resistant Enterobacteriaceae
por: Schoepp, Nathan G., et al.
Publicado: (2020)

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse
por: Tamma, Pranita D, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4j971qb20t0at33rjptfkmid4t